1 follower
Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers.
Industries
Headquarters
Employees
Links
Daniel O’Connell
Rocket Pharmaceuticals
2 followers
Bristol-Myers Squibb
168 followers
Viatris
30 followers
Catalent
15 followers
Organon
14 followers
NYU Langone Health
12 followers
Cerebral
11 followers
PCI Pharma Services
6 followers
DispatchHealth
6 followers
Parexel
5 followers
West Pharmaceutical Services
5 followers
Discover companies